Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study

Background: Patients with lung cancer (LC) are at significantly higher risk of developing venous thromboembolism (VTE), which may lead to increased use of health resources and the cost of the disease management. The main aim of the study was to determine the cost of the management of VTE events in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio-Salvador, Ana Rosa, Escudero-Vilaplana, Vicente, Marcos Rodríguez, José Antonio, Mangues-Bafalluy, Irene, Bernardez, Beatriz, García Collado, Carlos, Collado-Borrell, Roberto, Alvarado Fernández, María Dolores, Chacón López-Muñiz, José Ignacio, Yébenes Cortés, María, Gómez Barrera, Manuel, Calleja-Hernández, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825488/
https://www.ncbi.nlm.nih.gov/pubmed/33419138
http://dx.doi.org/10.3390/ijerph18020394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825488/
https://www.ncbi.nlm.nih.gov/pubmed/33419138
http://dx.doi.org/10.3390/ijerph18020394

Ejemplares similares